Medical Condition News

RSS

Elixir Medical’s DESyne BD Novolimus Eluting Coronary Stent System receives CE Mark approval

Elixir Medical Corporation, a developer of product platforms that combine state-of-the-art medical devices with advanced pharmaceuticals, announced that it has received CE Mark approval for its DESyne BD Novolimus Eluting Coronary Stent System for the treatment of coronary artery disease.

29 Aug 2012

GeneTex to introduce new antibody against hypoxia-inducible factor 1alpha

GeneTex, Inc., a leading manufacturer of antibodies, has announced that they will be launching a new antibody against HIF1a (hypoxia-inducible factor 1alpha).

29 Aug 2012

Altheus Therapeutics initiates enrollment in Zoenasa Phase 2 study for ulcerative colitis

Altheus Therapeutics announced today it has randomized its first patient in a comparator-controlled Phase 2 efficacy study of Zoenasa, a novel combination therapy for ulcerative colitis (UC).

29 Aug 2012

Aeterna Zentaris commences enrollment in AEZS-130 Phase 2A trial for cancer cachexia

Aeterna Zentaris Inc. today announced that a first patient has been recruited for a Phase 2A trial with its ghrelin agonist, AEZS-130 in patients with cancer cachexia.

28 Aug 2012

Study raises cautionary note about preferential use of endovascular technique for ruptured AAA

A new study raises a cautionary note about the increasing use of a minimally invasive procedure to repair ruptured abdominal aortic aneurysms, according to vascular surgeon Dr. Jae Sung Cho of Loyola University Medical Center.

28 Aug 2012

Oxford University Press announces acquisition of American Journal of Hypertension

Oxford University Press (OUP) today announced that the esteemed American Journal of Hypertension will be joining the publisher's journal collection.

28 Aug 2012

Three Pulmatrix PUR118 clinical studies on COPD, asthma to be presented at ERS Annual Congress

Pulmatrix, Inc., a clinical stage biotechnology company creating novel inhaled therapeutics, announced today that three posters on its lead iCALM therapeutic, the first treatment developed utilizing its iSPERSE inhaled drug platform, will be presented at the European Respiratory Society (ERS) Annual Congress taking place September 1-5, 2012, in Vienna, Austria.

28 Aug 2012

Abbott receives CE Marking for ARCHITECT testosterone assay

Abbott announced today CE Marking (Conformite Europeenne) for a testosterone assay with improved sensitivity and clinical utility.

28 Aug 2012

Refrigerating coal-plant emissions would reduce levels of dangerous chemicals in air

Refrigerating coal-plant emissions would reduce levels of dangerous chemicals that pour into the air -- including carbon dioxide by more than 90 percent -- at a cost of 25 percent efficiency, according to a simple math-driven formula designed by a team of University of Oregon physicists.

28 Aug 2012

Study examines risk factors associated with Humvee injury risk to U.S. military personnel

A new report by researchers from the Johns Hopkins Center for Injury Research and Policy examines the risk factors for injuries to U.S. military personnel from crashes involving highly mobile multipurpose wheeled vehicles (HMMWVs), more commonly known as Humvees.

28 Aug 2012

Transcatheter renal denervation reduces blood pressure in real world patients

Renal denervation successfully treats patients with resistant hypertension in real world patient populations, according to a study presented at ESC Congress 2012. The findings were presented by Dr Darren Mylotte from France.

28 Aug 2012

Human Vaccines & Immunotherapeutics Special Focus provides critical view on cancer vaccines

In one of the most comprehensive peer-reviewed discussions on cancer vaccines and immunotherapeutics, a Special Focus in the journal Human Vaccines & Immunotherapeutics provides a critical view on cancer vaccines and a discussion on best approaches for the future.

28 Aug 2012

Heart healthy lifestyle could avoid up to 400 cardiac events and 200 deaths in Swedish PCI patients

Up to 400 cardiac events and 200 deaths in Swedish PCI patients could be avoided by following a heart healthy lifestyle, according to research from the SPICI study presented at ESC Congress 2012. The results were presented at ESC press conference by Professor Joep Perk from Linnaeus University and at the scientific session by Dr Roland CARLSSON.

28 Aug 2012

Herceptin® (trastuzumab) delivery methods: an interview with Dr Gustavo Ismael

Approximately 20% of all breast cancer patients have overexpression of HER2 (human epidermal growth factor receptor 2), resulting in a more aggressive phenotype, and a poor prognosis.

28 Aug 2012

Positive results from Spinifex’s EMA401 Phase 2 trial on postherpetic neuralgia

Spinifex Pharmaceuticals, an Australian pain drug development company, today announces positive headline results from the Phase 2 clinical trial of its lead product, EMA401, in postherpetic neuralgia (PHN), a painful condition that develops in some patients following herpes zoster (shingles) and where existing therapy does not relieve pain in all individuals.

28 Aug 2012

Global platelet reactivity effectively identifies ACS patients at high risk of ischemic events

Global platelet reactivity is more effective than responsiveness to clopidogrel in identifying acute coronary syndrome (ACS) patients at high risk of ischemic events, according to research presented at the ESC Congress today. The results from the RECLOSE 2-ACS study were presented by Dr Rossella Marcucci from Italy.

28 Aug 2012

Friedreich Ataxia Research Alliance, USF ARC to host ‘Understanding a Cure’ symposium

Scientists, clinicians and patients will gather at the University of South Florida's Center for Advanced Medical Learning and Simulation (CAMLS) in downtown Tampa Sept. 6 to share research insights and energize the search for a cure for Friedreich's ataxia and related disorders.

28 Aug 2012

Limited evidence supports medical intervention use in adolescents and young adults with autism

Vanderbilt University researchers studying interventions for adolescents and young adults with autism are reporting today that there is insufficient evidence to support findings, good or bad, for the therapies currently used.

28 Aug 2012

SAMHSA announces six new Statewide Family Network Program grants

The Substance Abuse and Mental Health Services Administration (SAMHSA) Administrator Pamela S. Hyde announced today the awarding of six new grants totaling up to $1.1 million over the next three years that will enhance state capacity and infrastructure to be more oriented to the needs of children and adolescents with a serious mental health condition.

28 Aug 2012

Study links maternal obesity to newborn death in sub-Saharan Africa

"For the first time researchers have discovered a link between overweight and obese mothers in sub-Saharan Africa and infant mortality," Jennifer James, founder of Mom Bloggers for Social Good, writes in this post in the Bill & Melinda Gate's "Impatient Optimists" blog.

28 Aug 2012

Medical Condition News

Elixir Medical’s DESyne BD Novolimus Eluting Coronary Stent System receives CE Mark approval

GeneTex to introduce new antibody against hypoxia-inducible factor 1alpha

Altheus Therapeutics initiates enrollment in Zoenasa Phase 2 study for ulcerative colitis

Aeterna Zentaris commences enrollment in AEZS-130 Phase 2A trial for cancer cachexia

Study raises cautionary note about preferential use of endovascular technique for ruptured AAA

Oxford University Press announces acquisition of American Journal of Hypertension

Three Pulmatrix PUR118 clinical studies on COPD, asthma to be presented at ERS Annual Congress

Abbott receives CE Marking for ARCHITECT testosterone assay

Refrigerating coal-plant emissions would reduce levels of dangerous chemicals in air

Study examines risk factors associated with Humvee injury risk to U.S. military personnel

Transcatheter renal denervation reduces blood pressure in real world patients

Human Vaccines & Immunotherapeutics Special Focus provides critical view on cancer vaccines

Heart healthy lifestyle could avoid up to 400 cardiac events and 200 deaths in Swedish PCI patients

Herceptin® (trastuzumab) delivery methods: an interview with Dr Gustavo Ismael

Positive results from Spinifex’s EMA401 Phase 2 trial on postherpetic neuralgia

Global platelet reactivity effectively identifies ACS patients at high risk of ischemic events

Friedreich Ataxia Research Alliance, USF ARC to host ‘Understanding a Cure’ symposium

Limited evidence supports medical intervention use in adolescents and young adults with autism

SAMHSA announces six new Statewide Family Network Program grants

Study links maternal obesity to newborn death in sub-Saharan Africa

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News